Are new painkillers on the horizon?

Some speculate that the FDA's latest warning about NSAIDs could prompt new drugs.

The Chicago Tribune recently posed an interesting question – "Will FDA warnings prompt innovation in over-the-counter painkillers?"

Their argument is that there has not been many new initiatives when it comes to this area.

"Not much new has happened in the realm of over-the-counter painkillers in recent decades," the newspaper wrote. "Aleve, or naproxen, hit the OTC market in 1994. Tylenol, which contains acetaminophen, was approved for OTC sales in 1959. Aspirin has been around for more than a century."

 

 

 

When ibuprofen was approved for over-the-counter use in the U.S., Ronald Reagan was president and Duran Duran’s “The Reflex” topped the Billboard chart. Could any new painkillers be on the way?  The Food and Drug Administration last week issued new warnings about the risk of heart attack and stroke from over-the-counter nonsteroidal anti-inflammatory drugs, or NSAIDs, including pain relievers ibuprofen and naproxen.

Read More at Chicago Tribune

Fresh from the show floor: pharma packaging innovations for 2026
Serialization mandates. Containment demands. Sterile barrier requirements. Our editors found the pharma packaging innovations addressing your biggest challenges at PACK EXPO Las Vegas. Get your free curated report now.
GET YOUR COPY
Fresh from the show floor: pharma packaging innovations for 2026
Recyclable pill bottles are gaining pharmacy ground
Aluminum and paper-based prescription bottles are moving from concept to commercial reality. Here's what pharmacy and packaging leaders need to know.
Read More
Recyclable pill bottles are gaining pharmacy ground